FANTINI, MASSIMO CLAUDIO
 Distribuzione geografica
Continente #
NA - Nord America 1.116
EU - Europa 736
AS - Asia 629
AF - Africa 48
SA - Sud America 33
OC - Oceania 32
Totale 2.594
Nazione #
US - Stati Uniti d'America 1.067
IT - Italia 362
CN - Cina 293
DE - Germania 59
IN - India 59
GB - Regno Unito 51
JP - Giappone 42
FR - Francia 40
ES - Italia 36
KR - Corea 34
TR - Turchia 33
CA - Canada 30
AU - Australia 27
VN - Vietnam 25
HK - Hong Kong 24
RU - Federazione Russa 20
EG - Egitto 19
BR - Brasile 18
IR - Iran 17
NL - Olanda 17
TH - Thailandia 17
MX - Messico 16
TW - Taiwan 15
BE - Belgio 13
FI - Finlandia 13
UA - Ucraina 13
ID - Indonesia 12
SE - Svezia 12
CZ - Repubblica Ceca 11
IE - Irlanda 11
AT - Austria 10
RO - Romania 10
SG - Singapore 10
HU - Ungheria 9
DK - Danimarca 8
DZ - Algeria 8
GR - Grecia 8
PK - Pakistan 7
PL - Polonia 7
ZA - Sudafrica 7
CL - Cile 6
KZ - Kazakistan 6
MY - Malesia 6
NG - Nigeria 6
PT - Portogallo 6
AE - Emirati Arabi Uniti 5
CO - Colombia 5
NZ - Nuova Zelanda 5
CH - Svizzera 4
IQ - Iraq 4
MO - Macao, regione amministrativa speciale della Cina 4
PH - Filippine 4
BO - Bolivia 3
BG - Bulgaria 2
CI - Costa d'Avorio 2
GH - Ghana 2
IL - Israele 2
JO - Giordania 2
MA - Marocco 2
MK - Macedonia 2
MQ - Martinica 2
QA - Qatar 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
AZ - Azerbaigian 1
BD - Bangladesh 1
BY - Bielorussia 1
EC - Ecuador 1
HR - Croazia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MT - Malta 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
RS - Serbia 1
SA - Arabia Saudita 1
SM - San Marino 1
UZ - Uzbekistan 1
Totale 2.594
Città #
Fairfield 117
Santa Cruz 92
Ashburn 81
Cagliari 79
Rome 56
Seattle 53
Houston 50
Ann Arbor 45
Cambridge 45
Woodbridge 41
Buffalo 29
Shanghai 27
Wilmington 24
Beijing 21
Guangzhou 21
Dong Ket 20
Chicago 17
Milan 17
Council Bluffs 14
Helsinki 13
Los Angeles 13
San Diego 13
London 12
Catania 11
Ottawa 11
Ankara 10
Austin 10
Florence 10
New York 10
Redmond 10
Sydney 10
Tehran 10
Yuseong-gu 10
Bangkok 9
Munich 9
Paris 9
Taipei 9
Central 8
Columbus 8
Hangzhou 8
Mineiros 8
Boardman 7
Istanbul 7
Konya 7
Las Vegas 7
Nanjing 7
Provo 7
San Clemente 7
Tempio Pausania 7
Tokyo 7
Bologna 6
Dallas 6
Dublin 6
Edinburgh 6
Mountain View 6
Naples 6
Nellore 6
Taldykorgan 6
Vienna 6
Bogotá 5
Brussels 5
Chengdu 5
Delhi 5
Frankfurt am Main 5
Henderson 5
Hyderabad 5
Lahore 5
Muizenberg 5
Phoenix 5
San Jose 5
Seoul 5
Shenyang 5
Shenzhen 5
Wuhan 5
Athens 4
Barcelona 4
Bengaluru 4
Brampton 4
Brisbane 4
Bucharest 4
Budapest 4
Cairo 4
Changchun 4
Changsha 4
Chennai 4
Copenhagen 4
Giza 4
Guwahati 4
Hanoi 4
Harbin 4
Heroica Caborca 4
Jacksonville 4
Madrid 4
Melbourne 4
Nantong 4
Orono 4
Osaka 4
Portland 4
Singapore 4
Southampton 4
Totale 1.366
Nome #
Quercetin and its derivates as antiviral potentials: A comprehensive review, file e2f56eda-83bd-3eaf-e053-3a05fe0a5d97 757
Dual Targeted Therapy: a possible option for the management of refractory Inflammatory Bowel Disease, file e2f56ed9-51f7-3eaf-e053-3a05fe0a5d97 425
The Role of Gut Microbiota Biomodulators on Mucosal Immunity and Intestinal Inflammation, file e2f56ed9-7210-3eaf-e053-3a05fe0a5d97 274
The Resolution of Intestinal Inflammation: The Peace-Keeper's Perspective, file e2f56ed8-8217-3eaf-e053-3a05fe0a5d97 178
Interleukin-21 sustains inflammatory signals that contribute to sporadic colon tumorigenesis, file e2f56ed8-6965-3eaf-e053-3a05fe0a5d97 109
A functional role for Smad7 in sustaining colon cancer cell growth and survival, file e2f56ed8-c1c0-3eaf-e053-3a05fe0a5d97 106
Tbet Expression in Regulatory T Cells Is Required to Initiate Th1-Mediated Colitis, file e2f56ed8-ae32-3eaf-e053-3a05fe0a5d97 101
Smad7 knockdown activates protein kinase RNA-associated eIF2α pathway leading to colon cancer cell death, file e2f56ed8-d1f5-3eaf-e053-3a05fe0a5d97 99
Phase I clinical trial of Smad7 knockdown using antisense oligonucleotide in patients with active Crohn's disease, file e2f56ed8-6967-3eaf-e053-3a05fe0a5d97 95
Reciprocal regulation between Smad7 and Sirt1 in the gut, file e2f56ed8-bdb2-3eaf-e053-3a05fe0a5d97 93
Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD clinical guidelines based on the GRADE methodology, file e2f56eda-4d25-3eaf-e053-3a05fe0a5d97 87
Nonalcoholic fatty liver disease in patients with inflammatory bowel disease: Beyond the natural history, file e2f56ed9-779c-3eaf-e053-3a05fe0a5d97 81
Multidimensional Impact of Mediterranean Diet on IBD Patients, file e2f56ed9-720e-3eaf-e053-3a05fe0a5d97 51
Tumor infiltrating regulatory t cells in sporadic and colitis-associated colorectal cancer: The red little riding hood and the wolf, file e2f56ed9-98f2-3eaf-e053-3a05fe0a5d97 40
Telemedicine and remote screening for COVID-19 in inflammatory bowel disease patients: results from the SoCOVID-19 survey, file e2f56eda-7104-3eaf-e053-3a05fe0a5d97 19
Comparison of two strategies for the management of postoperative recurrence in Crohn's disease patients with one clinical risk factor: A multicentre IG-IBD study, file 38804133-9ab1-4584-b362-52553cdf5cc7 16
Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study, file 2377ad68-6d21-44b6-a11e-47b20158921a 14
Telemedicine in inflammatory bowel disease from its origin to the post pandemic golden age: A narrative review, file c08dcc77-f7d3-4239-8271-80f2d309d11e 11
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care, file e2f56eda-9996-3eaf-e053-3a05fe0a5d97 9
Defining Comprehensive Disease Control for use as a Treatment Target for Ulcerative Colitis in Clinical Practice: International Delphi Consensus Recommendations, file aef05027-5f68-460a-815a-3e1d2cd7a79b 7
Lack of Seroconversion Following COVID-19 Vaccination Is an Independent Risk Factor for SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: Data from ESCAPE-IBD, an IG-IBD Study, file a910c7d9-0cc2-41a9-a129-ff96cdc3cf1e 6
Use of biologics for the management of Crohn's disease: IG-IBD clinical guidelines based on the GRADE methodology, file b6269de8-694a-4755-aa11-35ee6513a076 6
Inhibitory Effect of Quercetin on Oxidative Endogen Enzymes: A Focus on Putative Binding Modes, file f5aa94cf-ca5e-4639-a38d-9cd9723625c2 6
Timing of proper introduction, optimization and maintenance of anti-TNF therapy in IBD: Results from a Delphi consensus, file 782b9130-939f-4aba-bc45-fb2438ab3660 5
Personalize, participate, predict, and prevent: 4Ps in inflammatory bowel disease, file 1628a615-c0b2-4295-b457-ae6672a64db6 4
Multiple Orocutaneous Extraintestinal Manifestations in Ulcerative Colitis Patient: Complete Response to Ustekinumab, file a76a932c-ed53-45a3-ae03-c96a2d430d89 4
A Pharmacological Batch of Mongersen that Downregulates Smad7 is Effective as Induction Therapy in Active Crohn’s Disease: A Phase II, Open-Label Study, file e2f56eda-451c-3eaf-e053-3a05fe0a5d97 4
In vitro generation of CD4+ CD25+ regulatory cells from murine naive T cells, file e2f56ed8-8313-3eaf-e053-3a05fe0a5d97 3
TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling, file e2f56ed8-9e98-3eaf-e053-3a05fe0a5d97 3
Unique role of junctional adhesion molecule-A in maintaining mucosal homeostasis in inflammatory bowel disease, file e2f56ed8-c7ce-3eaf-e053-3a05fe0a5d97 3
GPR120/FFAR4: A Potential New Therapeutic Target for Inflammatory Bowel Disease, file eec58a2a-1abb-43f7-b8a4-e2d7b2aa02b9 3
Diagnostic delay in adult coeliac disease: An Italian multicentre study, file 22dcbe32-b951-4b41-a5f7-95ff02d2b6b3 2
Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn's disease, file e2f56ed8-83d3-3eaf-e053-3a05fe0a5d97 2
Are we choosing wisely for inflammatory bowel disease care? The IG-IBD choosing wisely campaign, file e2f56ed8-b8bc-3eaf-e053-3a05fe0a5d97 2
Involvement of interleukin-21 in the regulation of colitis-associated colon cancer, file e2f56ed8-c056-3eaf-e053-3a05fe0a5d97 2
IL-21 comes of age as a regulator of effector T cells in the gut, file e2f56ed8-c4db-3eaf-e053-3a05fe0a5d97 2
CCL20 Is Negatively Regulated by TGF-β1 in Intestinal Epithelial Cells and Reduced in Crohn's Disease Patients With a Successful Response to Mongersen, a Smad7 Antisense Oligonucleotide, file e2f56ed9-1bbf-3eaf-e053-3a05fe0a5d97 2
Response Assessed by Ultrasonography as Target of Biological Treatment for Crohn's Disease, file e2f56ed9-71fa-3eaf-e053-3a05fe0a5d97 2
Comparative Efficacy of Vedolizumab and Adalimumab in Ulcerative Colitis Patients Previously Treated With Infliximab, file e2f56ed9-780b-3eaf-e053-3a05fe0a5d97 2
Immune system and gut microbiota senescence in elderly IBD patients, file e2f56eda-4d26-3eaf-e053-3a05fe0a5d97 2
An Objective Comparison of Vedolizumab and Ustekinumab Effectiveness in Crohn's Disease Patients' Failure to TNF-Alpha Inhibitors, file a052e517-c6f4-49b1-8c35-954b4138f044 1
Alternative Splice Forms of CYLD Mediate Ubiquitination of SMAD7 to Prevent TGFB Signaling and Promote Colitis, file d9442226-ce5e-43cd-bbcb-a7a31de39503 1
A phase 1 open-label trial shows that smad7 antisense oligonucleotide (GED0301) does not increase the risk of small bowel strictures in Crohn's disease, file e2f56ed8-6969-3eaf-e053-3a05fe0a5d97 1
Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth, file e2f56ed8-8308-3eaf-e053-3a05fe0a5d97 1
Reprogramming the immune system in IBD, file e2f56ed8-830c-3eaf-e053-3a05fe0a5d97 1
RORGT-expressing tregs drive the growth of colitis-associated colorectal cancer by controlling IL6 in dendritic cells, file e2f56ed8-83d6-3eaf-e053-3a05fe0a5d97 1
Activation of TGF-β-induced non-Smad signaling pathways during Th17 differentiation, file e2f56ed8-97fe-3eaf-e053-3a05fe0a5d97 1
Smad7 induces plasticity in tumor-infiltrating Th17 cells and enables TNF-alpha-mediated killing of colorectal cancer cells, file e2f56ed8-983f-3eaf-e053-3a05fe0a5d97 1
EBV-induced gene 3 transcription is induced by TLR signaling in primary dendritic cells via NF-kappa B activation, file e2f56ed8-9bd7-3eaf-e053-3a05fe0a5d97 1
Cutting edge: trans-signaling via the soluble IL-6R abrogates the induction of FoxP3 in naive CD4+CD25 T cells, file e2f56ed8-9d4a-3eaf-e053-3a05fe0a5d97 1
High resolution colonoscopy in live mice, file e2f56ed8-9d4b-3eaf-e053-3a05fe0a5d97 1
The impact of translational research on gastroenterology, file e2f56ed8-9d86-3eaf-e053-3a05fe0a5d97 1
A failure of transforming growth factor-beta1 negative regulation maintains sustained NF-kappaB activation in gut inflammation, file e2f56ed8-9e97-3eaf-e053-3a05fe0a5d97 1
Spatiotemporal patterns of expression of neurotrophins and neurotrophin receptors in mice suggest functional roles in testicular and epididymal morphogenesis, file e2f56ed8-9efc-3eaf-e053-3a05fe0a5d97 1
Use of biosimilars in inflammatory bowel disease: a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD), file e2f56ed8-a23a-3eaf-e053-3a05fe0a5d97 1
In vivo imaging of colitis and colon cancer development in mice using high resolution chromoendoscopy, file e2f56ed8-a78e-3eaf-e053-3a05fe0a5d97 1
Involvement of interleukin-21 in the regulation of colitis-associated colon cancer, file e2f56ed8-b367-3eaf-e053-3a05fe0a5d97 1
Outcome in ulcerative colitis after switch from adalimumab/golimumab to infliximab: A multicenter retrospective study, file e2f56ed8-b53a-3eaf-e053-3a05fe0a5d97 1
null, file e2f56ed8-b53d-3eaf-e053-3a05fe0a5d97 1
Angiogenesis, immune system and growth factors: new targets in colorectal cancer therapy, file e2f56ed8-c00d-3eaf-e053-3a05fe0a5d97 1
Update on the Therapeutic Efficacy of Tregs in IBD: Thumbs up or Thumbs down?, file e2f56ed8-c53f-3eaf-e053-3a05fe0a5d97 1
IL-6 signaling promotes tumor growth in colorectal cancer, file e2f56ed8-caa2-3eaf-e053-3a05fe0a5d97 1
Heligmosomoides polygyrus bakeri infection decreases Smad7 expression in intestinal CD4+ T cells, which allows TGF-b to induce IL-10–producing regulatory T cells that block colitis, file e2f56ed8-cd52-3eaf-e053-3a05fe0a5d97 1
Outcomes of COVID-19 in 79 patients with IBD in Italy: An IG-IBD study, file e2f56ed9-7211-3eaf-e053-3a05fe0a5d97 1
Immunological Variables Associated With Clinical and Endoscopic Response to Vedolizumab in Patients With Inflammatory Bowel Diseases, file e2f56ed9-7214-3eaf-e053-3a05fe0a5d97 1
Dual Targeted Therapy: a possible option for the management of refractory Inflammatory Bowel Disease, file e2f56ed9-8a93-3eaf-e053-3a05fe0a5d97 1
Smad7 in intestinal CD4+ T cells determines autoimmunity in a spontaneous model of multiple sclerosis, file e2f56ed9-d628-3eaf-e053-3a05fe0a5d97 1
Expert consensus paper on the use of Vedolizumab for the management of patients with moderate-to-severe Inflammatory Bowel Disease, file e2f56eda-09f7-3eaf-e053-3a05fe0a5d97 1
From inflammation to colitis-associated colorectal cancer in inflammatory bowel disease: Pathogenesis and impact of current therapies, file e2f56eda-7094-3eaf-e053-3a05fe0a5d97 1
Seroprevalence of SARS-CoV2 in IBD patients treated with biologic therapy, file e2f56eda-763a-3eaf-e053-3a05fe0a5d97 1
Advanced imaging and Crohn's disease: An overview of clinical application and the added value of artificial intelligence, file f0ecf15a-acf9-4838-8173-50ea48101b44 1
Totale 2.668
Categoria #
all - tutte 6.893
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.893


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020254 0 0 0 0 40 50 38 31 37 23 15 20
2020/2021236 12 28 11 15 20 21 10 16 13 15 13 62
2021/2022520 34 21 33 48 49 44 30 27 30 33 115 56
2022/2023661 49 37 106 50 36 27 28 44 48 73 61 102
2023/2024997 121 102 114 137 153 98 97 67 65 43 0 0
Totale 2.668